PharmaCyte Biotech's market cap is currently ―. The company's EPS TTM is $-1.196; its P/E ratio is -1.76; PharmaCyte Biotech is scheduled to report earnings on March 16, 2022, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.

	Oct 23	Jul 23	Apr 23	Jan 23	Oct 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ 2.79M	$ -3.18M	-	$ -1.40M	$ -1.88M
EBITDA	$ 2.79M	$ -3.18M	-	-	$ -1.88M
Net Income Common Stockholders	$ -2.26M	$ -3.50M	-	$ -764.14K	$ -1.88M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 73.43M	$ 74.66M	$ 68.04M	$ 72.64M	$ 76.96M
Total Assets	$ 78.88M	$ 79.88M	$ 73.28M	$ 77.95M	$ 82.35M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -73.43M	$ -74.66M	$ -68.04M	$ -72.64M	$ -76.96M
Total Liabilities	$ 20.81M	$ 37.15M	$ 586.58K	$ 827.83K	$ 1.31M
Stockholders Equity	$ 36.77M	$ 42.73M	$ 72.69M	$ 77.12M	$ 81.04M
Cash Flow	-
Free Cash Flow	$ -1.98M	$ 342.96K	-	-	$ -1.88M
Operating Cash Flow	$ -1.98M	$ 342.96K	-	-	$ -1.88M
Investing Cash Flow	-	-	-	-	$ 0.00
Financing Cash Flow	$ 748.69K	$ 6.28M	-	-	$ -3.39M

Currency in USD

PharmaCyte Biotech Earnings and Revenue History

Income Statement >

PharmaCyte Biotech Debt to Assets

Balance Sheet >

PharmaCyte Biotech Cash Flow

Cash Flow >

PharmaCyte Biotech Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing